Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in KONE Corporation's holding of treasury shares

KONE Corporation, stock exchange release, August 9, 2016 at 2.15 p.m. EEST Change in KONE Corporation's holding of treasury shares A total of 21,752 KONE class B shares have been returned free of consideration to KONE Corporation by virtue of the terms of KONE Corporation's share-based incentive program for the years 2013-2015.The date of the returning of the shares was August 9, 2016. After the transaction, KONE Corporation holds 12,867,711 of its own class B shares. For further information, please contact:Jukka Ala-Mello, Secretary to the Board, tel. +358 (0)204 75 4226

Notification regarding transaction by Valmet Oyj's manager

Valmet Oyj's stock exchange release on August 9, 2016 at 2:00 p.m. EET Valmet Oyj's manager Bertel Karlstedt has made a transaction with Valmet Oyj's financial instrument. Person subject to the notification requirementName: Karlstedt, BertelPosition: Other senior manager Initial NotificationReference number: 213800D9O7FUQDH83V62_20160808171456_2 IssuerName: ValmetLEI: 213800D9O7FUQDH83V62 Transaction detailsTransaction date: 2016-08-08

ECO Animal Health’s mycoplasma treatment approved with zero day egg withdrawal in the EU

August 9, 2016Aivlosin® Water Soluble Granules, the mycoplasma treatment from ECO Animal Health, has been granted a zero day egg withdrawal time by the European Medicines Agency (EMA). The product treats Mycoplasmosis (Mycoplasma gallisepticum – Mg) – which typically causes chronic respiratory disease in chickens. Aivlosin® is mixed into the animals’ drinking water and acts quickly to concentrate at the site of infection, achieving peak plasma levels within two hours – rapidly attacking the disease. Global Marketing Director at ECO Animal Health, Marc Coulier, says the new zero day

Leading Belgian teaching hospital selects RayStation

RayStation® will automate workflows and support larger-scale adaptive planning at AZ Sint-Jan Brugge – Oostende AV Hospital.AZ Sint-Jan Brugge – Oostende AV Hospital, a leading Belgian teaching hospital, has selected RayStation as the sole treatment planning system for the expanding radiation therapy department at its campus in Bruges. RayStation will replace the department’s existing system and will support treatment planning for existing linacs, as well as two newly purchased machines. RayStation will enable the department to simplify and optimize its workflows, and to take strides in

Glaston Half Year Financial Report 1 January – 30 June 2016: Order intake picked up from the early part of the year

GLASTON CORPORATION           HALF YEAR FINANCIAL REPORT   9 AUGUST 2016 AT 13.00Glaston Half Year Financial Report 1 January – 30 June 2016:  Order intake picked up from the early part of the year This release is a summary of Glaston Corporation's half year financial report January-June 2016. The complete report is attached to this release as a pdf-file. The stock exchange release is also available on the company's website at the address www.glaston.net.ESMA (European Securities and Markets Authority) has published new guidelines on alternative performance measures. As a result,

Glaston planning efficiency measures in Finland

Glaston Corporation               Press release                          9.8.2016 at 12.45Glaston planning efficiency measures in Finland  Glaston will initiate consultations with personnel on the possible need for lay-offs and job reductions. The consultations will cover all Glaston personnel in Finland.The need for personnel redundancies is expected to be approximately 10 people, and the need for lay-offs to be less than 90 days. The possible lay-offs would be implemented during autumn 2016 and spring 2017. The planned measures may also result in changes to employment terms, working

Pure Imagination: Roald Dahl Interiors from Brewers Home

With Roald Dahl Day coming up on 13th September, celebrating 100 years since the famous children's author was born, and the release of the new BFG film, Brewers Home give some inspiration for children's bedrooms in the form of their Roald Dahl collectionA child's bedroom is a place of creativity, safety, play and above all, pure imagination. It's important that children have a place to escape to, a place they feel reflects their interests and personality – even a place for a bit of nonsense! Many will be inspired by characters from their favourite books, and with Roald Dahl Day coming up on

Digital prediction software is featured in international market

Synaption platform is able to analyze large data to anticipate important scenariosSearch engine innovation. This has been the main goal of most technology companies specialized in data analytics market. The activity consists in evaluating and interpreting large amounts of data to visualize scenarios in advance what is so-called “digital prediction”. An effective example of data analysis tool that has recently been highlighted in international market is in the Synaption project. The platform was born in 2014 derived from the same research that generated the main data crossing tools used

NeuroVive’s novel strategy for treatment of mitochondrial disease published in Nature Communications

Lund, Sweden, August 9, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that research results from the NVP015 program investigating a novel pharmacological strategy for the treatment of mitochondrial disease has been published in Nature Communications, the third highest ranked multidisciplinary scientific journal in the world. The research was performed in collaboration between NeuroVive and Lund University, Newcastle University, Selcia/Mitopharm Ltd and Isomerase Therapeutics Ltd.In the Nature Communications (

Cheshire’s summer shows become a showcase for Thrive Creative’s clients!

Two of Cheshire’s biggest summer events – the Royal Cheshire Show and the Nantwich Show – took on an extra dimension this year, with a number of the key exhibitors being clients of Cheshire-based Brand Communications Agency, Thrive Creative!At the Cheshire Show in late June one of the main attractions was the ‘Cycling Village’, created specially to highlight the coming visit of the Tour of Britain cycle race in September. Thrive have already created the distinctive ‘Cheshire Tour of Britain’ identity and website, and used these concepts to add the cycling theme to Cheshire East’s marquee

Saab Receives Order From FMV For Carl-Gustaf Ammunition

Defence and security company Saab has received an order from the Swedish Defence Material Administration (FMV) for deliveries of Carl-Gustaf ammunition to the Swedish Army. The order value amounts to approximately SEK122 million and final delivery will take place during 2017.Since 1948, the Carl-Gustaf multi-purpose weapon system has been supporting dismounted infantry around the world in dealing with a full range of battlefield challenges, and for decades, the system has been in service within the Swedish Army. “With this order, of both live and training ammunition, the Swedish Armed

Sari Mannonen appointed Vice President, UPM Biofuels Business Unit

(UPM, Helsinki, 9 August 2016 at 11:00 EET) - Sari Mannonen has been appointed Vice President, responsible for UPM Biofuels Strategic Business Unit as of 9 August 2016. Mannonen previously worked as Director, Sales and Marketing within UPM Biofuels and was in that role since 2014, responsible for commercial strategy and product launches in Biofuels business. Mannonen has worked for UPM since 2011 in leadership positions and before joining the company she worked for Lindström and Biohit. She will be based in Helsinki and report to Heikki Vappula, Executive Vice President, UPM

SimCorp A/S – Share buyback program

On 10 May 2016 SimCorp A/S announced a share buyback program in compliance with the provisions of Commission Regulation No. 2273/2003 of 22 December 2003, also referred to as the “Safe Harbour”. As of 3 July 2016 the program is carried out in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 40.0m (approx. DKK 297.6m) in the period from 10 May 2016 to 20

KID ASA - INVITATION TO PRESENTATION OF SECOND QUARTER 2016 RESULTS

Lier, 9 August 2016: Kid ASA will release its second quarter 2016 results on Tuesday 16 August 2016. The quarterly report and presentation material will be available on http://investor.kid.no and http://newsweb.no from 07:00 CET. The results will be presented at 09:00 CET by CEO Kjersti Hobøl and CFO Petter Schouw-Hansen. The presentation will take place at ABG Sundal Collier offices in Munkedamsveien 45e, 7th floor, in Oslo. If you want to attend the presentation, please register by email to Hanne.Sandaas@abgsc.no. ENQUIRIESKjersti Hobøl, CEO Kid, +47 918 35 965Petter Schouw-

Klas Nilsson new Director Group Communications of Boliden

Klas Nilsson has been appointed new Director Group Communications for the Boliden Group, and will take up his position on 1 October 2016.Klas Nilsson will be responsible for Boliden’s overall communications work and will handle the Group’s press contacts. Klas replaces Marcela Sylvander, who earlier this year took up the position of Director Communication and Public Affairs with the Swedish Armed Forces.Klas Nilsson has a degree from Umeå University and his most recent position was as Head of Strategic Communications at Swedavia. He has been working at Swedavia since 2011, prior

Rabbalshede Kraft signs service and maintenance agreement with Gnosjö Energy

Rabbalshede Kraft has signed a four-year management agreement with Gnosjö Energy, to manage the wind farm Kulltorp, located in Gnosjö municipality.Rabbalshede will be responsible for the management and operation monitoring for Gnosjö Energy's four wind turbines with an installed capacity of 10 MW and a yearly production of about 22.5 GWh of electricity. "We are very happy to receive this mandate from Gnosjö Energy and are looking forward to work with them. The agreement is part of Rabbalshede strategy, that in addition to managing our own farms we also offer services to other operators

INDUCT AS - REPAIR ISSUE COMPLETED

Reference is made to the stock exchange announcement dated 25 July 2016 related to the repair issue (the “Repair Issue”) in Induct AS (“Induct” or the “Company”). The Repair Issue was successfully completed with the subscription period ending on 8 August 2016 at 16:30 CET. 72 investors participated in the Repair Issue through the subscription of 96,716 new shares (the “New Shares”) at a subscription price of NOK 19 per share (“Subscription Price”).   Notification of allocation will be submitted to investors subscribing in the Repair Issue today. Payment for the subscribed shares is

DOF ASA – Repurchase of convertible bonds

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THE ANNOUNCEMENT. DOF ASA – Repurchase of convertible bonds Reference is made to previous stock exchange announcements regarding (i) the rights issue (the "Rights Issue") by DOF ASA ("DOF" or the "Company") of 1,059,869,

Watching cartoons could help children overcome anxiety of dental treatment

Watching cartoons through video glasses during dental treatment could help lessen children’s anxiety and distress as well as reducing disruptive behaviour, according to a randomized controlled trial published in Acta Odontologia Scandinavica .Anxiety about visiting the dentist and during treatment is common in children. Estimates suggest that as many as 1 in 5 school age children are afraid of dentists. Children with dental phobias end up experiencing more dental pain and are more disruptive during treatment. Although

Enea® Linux the first commercial Linux distribution with Yocto ProjectTM 2.1

Enea Linux 6 with new networking profile available now! STOCKHOLM, Sweden, August 9, 2016 – Enea® (NASDAQ OMX Nordic:ENEA), providing software platforms and services to the connected society, today announced version 6 of Enea Linux; A comprehensive cross-development tool chain and runtime environment for common target architectures, bringing customers the absolute latest advancements in open source technology.Enea introduces Enea Linux 6 a new Networking Profile designed for communications challenges, based on the latest Yocto Project version (2.1) and configured for the NXP QorIQ P2041

Publishing of Apetit Plc’s half year financial report for January-June 2016 and invitation to a briefing

Apetit Plc will publish its half year financial report for January-June 2016 on Tuesday 16[th] August 2016 at 8:30 a.m. Finnish time. A briefing (in Finnish) for analysts and media will be held on the same day at 10:00 a.m. in Hotel Scandic Simonkenttä, meeting room Espa, (address: Simonkatu 9, Helsinki). The presentation material will be also published on company web pages at www.apetitgroup.fi/en after the event.  In the briefing Apetit Plc’s CEO Juha Vanhainen presents the second quarter financial report and gives more information about other actual matters.  Please inform of

DESTIA’S BUSINESS DEVELOPED POSITIVELY IN THE FIRST HALF OF THE YEAR

Destia Group Plc STOCK EXCHANGE RELEASE 9.8.2016 at 9.00 (CET +1) This is a summary of the Destia’s Half year financial report for January-June 2016. The complete report with tables is attached to this release and available at www.destia.fi/en Destia’s Half year financial report January−June 2016 DESTIA’S BUSINESS DEVELOPED POSITIVELY IN THE FIRST HALF OF THE YEAR ·Revenue increased by 11.4 per cent, to MEUR 200.1 (179.6). ·Operating result improved with respect to the comparison period and was MEUR -1.2 (-3.7). ·The order book was MEUR 800.2 (821.4).

ASTRAZENECA UPDATE ON SELUMETINIB PHASE III TRIAL

This announcement contains inside information 09 August 2016 07:00 ASTRAZENECA PROVIDES UPDATE ON PHASE III TRIAL OF SELUMETINIB IN NON-SMALL CELL LUNG CANCER Selumetinib did not meet trial endpoint of progression-free survival in KRASm NSCLC patients AstraZeneca today announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib, in combination with docetaxel chemotherapy as 2nd-line treatment in patients with KRAS mutation-positive (KRASm) locally-advanced or metastatic non-small cell lung cancer (NSCLC). The results showed that the trial did not

Moberg Pharma AB Interim Report January – June 2016

ACQUISITION DOUBLES OPERATIONS IN THE U.S.FIRST SIX MONTHS (JAN-JUN 2016)* ·  Revenue MSEK 140.7 (165.3) ·  EBITDA MSEK 31.8 (28.5) ·  EBITDA for Commercial Operations MSEK 43.4 (41.9) ·  Operating profit (EBIT) MSEK 31.8 (23.2) ·  Net profit after tax MSEK 22.3 (16.4) ·  Earnings per share SEK 1.56 (1.13) ·  Operating cash flow per share SEK -0.16 (pos: 1.20) SECOND QUARTER (APR-JUN 2016)*  ·  Revenue MSEK 71.3 (92.2) ·  EBITDA MSEK 31.2 (11.1) ·  EBITDA for Commercial Operations MSEK 36.4 (16.3) ·  Operating profit (EBIT) MSEK 31.2 (8.3) ·  Net

There are no items matching the current filter
There are no more items matching the current filter
Back to top